All In Biotech

Free tool

FAERS Monitor: Favlyxa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 220201 or its brand name (Favlyxa, Fluorouracil). Reports on generic versions are filed under their own applications.

Reports

77,573

Serious

0

0% of reports

Hospitalization

31,278

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea7,076
  • neutropenia5,294
  • nausea5,063
  • vomiting4,037
  • off label use3,617
  • neuropathy peripheral3,541
  • fatigue3,319
  • disease progression3,293
  • pyrexia3,085
  • thrombocytopenia3,036
  • febrile neutropenia2,915
  • anaemia2,610
  • asthenia2,589
  • drug ineffective2,238
  • malignant neoplasm progression2,217

Reports by year received

View as table
YearReports

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,586 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (500). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal2,91512.412.029,336
neutropeniaSignal5,29410.910.746,261
disease progressionSignal3,2937.77.518,867
thrombocytopeniaSignal3,0367.57.316,834
malignant neoplasm progressionSignal2,2176.05.79,029
anaemiaSignal2,6103.73.65,231
diarrhoeaSignal7,0763.02.99,587
pyrexiaSignal3,0852.42.32,615
vomitingSignal4,0372.32.33,139
asthenia2,5891.91.81,064
nausea5,0631.71.71,642
fatigue3,3191.21.173
off label use3,6171.11.149
drug ineffective2,2380.50.41,515
neuropathy peripheral3,5410.00.0957,415

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.